The "beta-clasp" model of apolipoprotein A-I--a lipid-free solution structure determined by electron paramagnetic resonance spectroscopy
- PMID: 22245143
- PMCID: PMC3402359
- DOI: 10.1016/j.bbalip.2011.12.010
The "beta-clasp" model of apolipoprotein A-I--a lipid-free solution structure determined by electron paramagnetic resonance spectroscopy
Abstract
Apolipoprotein A-I (apoA-I) is the major protein component of high density lipoproteins (HDL) and plays a central role in cholesterol metabolism. The lipid-free/lipid-poor form of apoA-I is the preferred substrate for the ATP-binding cassette transporter A1 (ABCA1). The interaction of apoA-I with ABCA1 leads to the formation of cholesterol laden high density lipoprotein (HDL) particles, a key step in reverse cholesterol transport and the maintenance of cholesterol homeostasis. Knowledge of the structure of lipid-free apoA-I is essential to understanding its critical interaction with ABCA1 and the molecular mechanisms underlying HDL biogenesis. We therefore examined the structure of lipid-free apoA-I by electron paramagnetic resonance spectroscopy (EPR). Through site directed spin label EPR, we mapped the secondary structure of apoA-I and identified sites of spin coupling as residues 26, 44, 64, 167, 217 and 226. We capitalize on the fact that lipid-free apoA-I self-associates in an anti-parallel manner in solution. We employed these sites of spin coupling to define the central plane in the dimeric apoA-I complex. Applying both the constraints of dipolar coupling with the EPR-derived pattern of solvent accessibility, we assembled the secondary structure into a tertiary context, providing a solution structure for lipid-free apoA-I. This article is part of a Special Issue entitled Advances in High Density Lipoprotein Formation and Metabolism: A Tribute to John F. Oram (1945-2010).
Copyright © 2012 Elsevier B.V. All rights reserved.
Figures




Similar articles
-
The secondary structure of apolipoprotein A-I on 9.6-nm reconstituted high-density lipoprotein determined by EPR spectroscopy.FEBS J. 2013 Jul;280(14):3416-24. doi: 10.1111/febs.12334. Epub 2013 Jun 10. FEBS J. 2013. PMID: 23668303 Free PMC article.
-
Lysine residues of ABCA1 are required for the interaction with apoA-I.Biochim Biophys Acta. 2012 Mar;1821(3):530-5. doi: 10.1016/j.bbalip.2011.06.024. Epub 2011 Jul 1. Biochim Biophys Acta. 2012. PMID: 21749932
-
Electron paramagnetic resonance spectroscopy of site-directed spin labels reveals the structural heterogeneity in the N-terminal domain of apoA-I in solution.J Biol Chem. 2007 Mar 23;282(12):9143-9. doi: 10.1074/jbc.M608717200. Epub 2007 Jan 4. J Biol Chem. 2007. PMID: 17204472
-
Lipid-free apoA-I structure - Origins of model diversity.Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Feb;1862(2):221-233. doi: 10.1016/j.bbalip.2016.11.010. Epub 2016 Nov 25. Biochim Biophys Acta Mol Cell Biol Lipids. 2017. PMID: 27890580 Review.
-
Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL.Biochim Biophys Acta. 2012 Mar;1821(3):490-501. doi: 10.1016/j.bbalip.2011.11.011. Epub 2011 Dec 10. Biochim Biophys Acta. 2012. PMID: 22178192 Free PMC article. Review.
Cited by
-
The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils.J Lipid Res. 2012 Mar;53(3):390-398. doi: 10.1194/jlr.M020883. Epub 2011 Dec 19. J Lipid Res. 2012. PMID: 22184756 Free PMC article.
-
Effects of niacin and omega-3 fatty acids on HDL-apolipoprotein A-I exchange in subjects with metabolic syndrome.PLoS One. 2024 Feb 26;19(2):e0296052. doi: 10.1371/journal.pone.0296052. eCollection 2024. PLoS One. 2024. PMID: 38408107 Free PMC article. Clinical Trial.
-
A consensus model of human apolipoprotein A-I in its monomeric and lipid-free state.Nat Struct Mol Biol. 2017 Dec;24(12):1093-1099. doi: 10.1038/nsmb.3501. Epub 2017 Nov 13. Nat Struct Mol Biol. 2017. PMID: 29131142 Free PMC article.
-
Apolipoprotein A-I exchange is impaired in metabolic syndrome patients asymptomatic for diabetes and cardiovascular disease.PLoS One. 2017 Aug 2;12(8):e0182217. doi: 10.1371/journal.pone.0182217. eCollection 2017. PLoS One. 2017. PMID: 28767713 Free PMC article. Clinical Trial.
-
Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle.J Lipid Res. 2013 May;54(5):1275-82. doi: 10.1194/jlr.M032904. Epub 2013 Mar 7. J Lipid Res. 2013. PMID: 23471027 Free PMC article.
References
-
- Miller NE, Miller GJ. Letter: High-density lipoprotein and atherosclerosis. Lancet. 1975;1:1033. - PubMed
-
- Glomset JA. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res. 1968;9:155–167. - PubMed
-
- Cuchel M, Rader DJ. Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? Circulation. 2006;113:2548–2555. - PubMed
-
- Adorni MP, Zimetti F, Billheimer JT, Wang N, Rader DJ, Phillips MC, Rothblat GH. The roles of different pathways in the release of cholesterol from macrophages. J Lipid Res. 2007;48:2453–2462. - PubMed
-
- Mulya A, Lee JY, Gebre AK, Thomas MJ, Colvin PL, Parks JS. Minimal lipidation of pre-beta HDL by ABCA1 results in reduced ability to interact with ABCA1. Arterioscler Thromb Vasc Biol. 2007;27:1828–1836. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous